Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S D Anker

Showing results (41-50 of 120) with videos related to

Pageof 12
Sort By:
Herz|January 5, 2002
[Tumor necrosis factor alpha in chronic heart failure. Clinical manifestation and therapeutic possibilities]S Genth-Zotz, A P Bolger, S D Anker
Cardiovascular Research|July 31, 2001
Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressinP R Kalra, S D Anker, A J Coats
European Heart Journal|July 2, 2002
Sympathetic activation and malignant ventricular arrhythmias: a molecular link?P R Kalra, P P Ponikowski, S D Anker
Heart Failure Monitor|March 14, 2003
The importance of tumor necrosis factor and lipoproteins in the pathogenesis of chronic heart failureR Sharma, F O Al-Nasser, S D Anker
British Heart Journal|October 1, 1995
Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failureT P Chua, S D Anker, D Harrington, et al.
Metabolism: Clinical and Experimental|September 29, 1998
Uric acid in chronic heart failure: a measure of the anaerobic thresholdF Leyva, T P Chua, S D Anker, et al.
International Journal of Cardiology|September 29, 1999
Three year mortality in heart failure patients with very low left ventricular ejection fractionsJ Niebauer, A L Clark, S D Anker, et al.
International Journal of Cardiology|January 15, 2000
Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocationF M Brunkhorst, A L Clark, Z F Forycki, et al.
International Journal of Cardiology|August 7, 2002
Cachexia: a therapeutic approach beyond cytokine antagonismS von Haehling, S Genth-Zotz, S D Anker, et al.
European Heart Journal|June 29, 2001
The role of C-type natriuretic peptide in cardiovascular medicineP R Kalra, S D Anker, A D Struthers, et al.
Pageof 12

Showing results (41-50 of 120) with videos related to

Sort By:
Pageof 12
Herz|January 5, 2002
[Tumor necrosis factor alpha in chronic heart failure. Clinical manifestation and therapeutic possibilities]S Genth-Zotz, A P Bolger, S D Anker
Cardiovascular Research|July 31, 2001
Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressinP R Kalra, S D Anker, A J Coats
European Heart Journal|July 2, 2002
Sympathetic activation and malignant ventricular arrhythmias: a molecular link?P R Kalra, P P Ponikowski, S D Anker
Heart Failure Monitor|March 14, 2003
The importance of tumor necrosis factor and lipoproteins in the pathogenesis of chronic heart failureR Sharma, F O Al-Nasser, S D Anker
British Heart Journal|October 1, 1995
Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failureT P Chua, S D Anker, D Harrington, et al.
Metabolism: Clinical and Experimental|September 29, 1998
Uric acid in chronic heart failure: a measure of the anaerobic thresholdF Leyva, T P Chua, S D Anker, et al.
International Journal of Cardiology|September 29, 1999
Three year mortality in heart failure patients with very low left ventricular ejection fractionsJ Niebauer, A L Clark, S D Anker, et al.
International Journal of Cardiology|January 15, 2000
Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocationF M Brunkhorst, A L Clark, Z F Forycki, et al.
International Journal of Cardiology|August 7, 2002
Cachexia: a therapeutic approach beyond cytokine antagonismS von Haehling, S Genth-Zotz, S D Anker, et al.
European Heart Journal|June 29, 2001
The role of C-type natriuretic peptide in cardiovascular medicineP R Kalra, S D Anker, A D Struthers, et al.
Pageof 12